SCHEMBL24709688

SCHEMBL24709688

COC(=O)c1cc(C(F)(F)F)nn1Cc1c(F)cccc1F

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 2/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ TSHR P16473 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ MAPK1 P28482 2/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ HTR1E P28566 1/20 0.41
▸ S1PR3 Q99500 1/20 0.41
▸ KLKB1 P03952 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ STIM1 Q13586 1/20 0.39
▸ ORAI1 Q96D31 1/20 0.39
▸ POLB P06746 2/20 0.39
▸ GRN P28799 1/20 0.39
▸ SORT1 Q99523 1/20 0.39
▸ GAA P10253 2/20 0.39
▸ TRPV1 Q8NER1 1/20 0.39
▸ RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31409379 0.76 TP53 (0.42) ALDH1A1TSHRKLKB1TP53L3MBTL1
SCHEMBL1498778 0.76 TP53 (0.43) ALDH1A1TSHRTP53L3MBTL1POLB
Hydrochloric Acid SCHEMBL34466698 0.73 TP53 (0.42) ALDH1A1TSHRNPSR1KLKB1TP53
SCHEMBL31537588 0.72 TP53 (0.44) ALDH1A1TSHRNPSR1TP53L3MBTL1
SCHEMBL19994223 0.71 KDM4E (0.47) ALDH1A1POLBGRNSORT1TRPV1
SCHEMBL22637701 0.71 POLB (0.67) ALDH1A1TSHRMAPTMAPK1NPSR1
SCHEMBL24758384 0.71 CRHR1 (0.42) TP53L3MBTL1POLBGAA
SCHEMBL24709684 0.71 RORC (0.36) RORCALDH1A1TSHRMAPTKLKB1
SCHEMBL19779589 0.71 KLKB1 (0.48) ALDH1A1MAPTMAPK1NPSR1KLKB1
SCHEMBL30122098 0.71 RORC (0.36) RORCALDH1A1TSHRMAPTKLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240294523-A1 HETEROCYCLIC LACTAM COMPOUND, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF GENFLEET THERAPEUTICS (SHANGHAI) INC. (CN) 2024-09-05 — — US disclosed
WO-2022258052-A1 HETEROCYCLIC LACTAM COMPOUND, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF 劲方医药科技(上海)有限公司 2022-12-15 — — WO disclosed
WO-2022258052-A1 HETEROCYCLIC LACTAM COMPOUND, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF 劲方医药科技(上海)有限公司 2022-12-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294523-A1 HETEROCYCLIC LACTAM COMPOUND, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF RIPK1, RIPK4, RIPK3 RORC 789/4885ALDH1A1 4023/4885TSHR 4717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback